High prevalence of neuroleptic drug use in elderly people with dementia;Alta prevalencia de consumo de neurolépticos en las personas ancianas con demencia

Medicina Clinica

Volumn 134, Issue 3, 2010, Pages 101-106

  Fort, Isabel ^a   Formiga, Francesc ^b   Robles, María José ^c   Regalado, Pedro ^d   Rodríguez, Daniel ^e   Barranco, Elena ^f  

^a Badalona Serveis Assistencials   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL DE L ESPERANÇA   (Spain)

^d Complex Assistencial en Salut Mental ^*  (Spain)

^e EAIA de Trastorns Cognitius   (Spain)

^f HOSPITAL GENERAL DE GRANOLLERS   (Spain)

Author keywords

Alzheimer's disease; Dementia; Elderly; Neuroleptic drugs; Psychoactive drugs

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; DONEPEZIL; GALANTAMINE; HALOPERIDOL; HYPNOTIC SEDATIVE AGENT; MEMANTINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; RIVASTIGMINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BARTHEL INDEX; COMORBIDITY; CONTROL GROUP; CONTROLLED STUDY; DEMENTIA; DEMOGRAPHY; DISEASE SEVERITY; DRUG USE; FEMALE; HUMAN; INSTITUTIONALIZATION; LAWTON INSTRUMENTAL ACTIVITIES OF DAILY LIVING SCALE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR;

AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; DEMENTIA; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE;

EID: 76149125139     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.07.046     Document Type: Article

References (32)

1. D. De Ronchi, D. Berardi, M. Menchetti, G. Ferrari, A. Serretti, E. Dalmonte, et al. Occurrence of cognitive impairment and dementia after the age of 60: A population based study from Northern Italy Dement Geriatr Cogn Disord 19 2005 97 105
2. C.G. Lyketsos, O. López, B. Jones, A.L. Fitzpatrick, J. Breinter, and S. DeKosky Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health Study JAMA 288 2002 1475 1483
3. F. Formiga, I. Fort, M.J. Robles, E. Barranco, M.C. Espinosa, and S. Riu Comorbilidad en pacientes ancianos con demencia. Diferencias por edad y género Rev Clin Esp 207 2007 495 500
4. K.M. Sink, K.F. Holden, and K. Yaffe Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence JAMA 293 2005 596 608
5. S. López-Pousa, J. Vilalta-Franch, J. Garre-Olmo, S. Pons, and M.G. Cucurella Caracterización y prevalencia de los síntomas psicológicos y conductuales en pacientes con demencia Rev Neurol 45 2007 683 688
6. F. Formiga, I. Fort, L. Reig, M.J. Robles, M.C. Espinosa, and D. Rodríguez Atrial fibrillation in elderly patients with dementia Gerontology 55 2009 202 204
7. F. Formiga, I. Fort, M.J. Robles, S. Riu, D. Rodríguez, and O. Sabartes Aspectos diferenciales de comorbilidad en pacientes ancianos con demencia tipo Alzheimer o con demencia vascular Rev Neurol 46 2008 72 76
8. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4 ed 1993 APA Washington, DC
9. B. Reisberg, S.H. Ferris, M.J. De León, and T. Crok The global deterioration scale for assessment of primary degenerative dementia Am J Psychiatry 139 1982 1136 1139
10. C. Mc Khann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
11. G.C. Román, T.K. Tatemichi, T. Erkinjuntti, J.L. Cummings, J.C. Masdeu, J.H. García, et al. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop Neurology 43 1993 250 260
12. I.G. Mc Keith, E.K. Perry, and R.H. Perry Report of the second dementia with Lewy body international workshop: Diagnosis and treatment. Consortium on dementia with Lewy bodies Neurology 53 1999 902 905
13. A. Brun, B. Englund, L. Gustafson, U. Passant, D.M.A. Mann, D. Neary, et al. The Lund and Manchester groups Clinical and neuropathological criteria for frontotemporal dementia J Neurol Neurosurg Psychiatry 57 1994 416 418
14. F.I. Mahoney, and D.W. Barthel Functional evaluation: The Barthel index. A simple index of independence useful in scoring improvement in the rehabilitation of the chronically ill Md State Med J 14 1965 61 65
15. M.P. Lawton, and E.M. Brody Assessment of older people: Self-maintaining and instrumental activities of daily living Gerontologist 9 1969 179 186
16. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
17. G. Feder, C. Cryer, S. Donovan, and Y. Carter Guidelines for the prevention of falls in people over 65 BMJ 321 2000 1007 1011
18. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation J Chronic Dis 40 1987 373 383
19. C. Ballard, I. Powell, I. James, K. Reichelt, P. Myint, D. Potkins, et al. Can psychiatric liason reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilities Int J Geriatr Psychiatry 17 2002 140 145
20. K. Yaffe, P. Fox, R. Newcomer, L. Sands, K. Lindquist, K. Dane, et al. Patient and caregiver characteristics and nursing home placement in patients with dementia JAMA 14;288 2002 696 697
21. P. Kamble, H. Chen, J. Sherer, and R.R. Aparasu Antipsychotic drug use among elderly nursing home residents in the United States Am J Geriatr Pharmacother 6 2008 187 197
22. J. Snowdon, S. Day, and W. Baker Why and how antipsychotic drugs are used in 40 Sydney nursing homes Int J Geriatr Psychiatry 20 2005 1146 1152
23. H. Aguero-Torres, V.S. Thomas, B. Winblad, and L. Fraglitioni The impact of somatic and cognitive disorders on the functional status of the elderly J Clin Epidemiol 55 2002 1007 1012
24. P. Mackin Cardiac side effects of psychiatric drugs Hum Psychopharmacol 23 2008 3 14
25. L.S. Schneider, P.N. Tariot, K.S. Dagerman, S.M. Davis, J.K. Hsiao, M.S. Ismail, et al. CATIE-AD Study Group Effectiveness of atipical antipsychotic drugs in patients with Alzheimer's disease N Engl J Med 355 2006 1525 1538
26. G.S. Alexopoulos, J. Streim, D. Carpenter, and J.P. Docherty Expert consensus panel for using antipsychotic drugs in older patients. Using antipsychotic drugs in older patients J Clin Psychiatry 65 2004 5 99
27. J. Pujol-Domenech, and P. Azpiazu Antipsicóticos en ancianos, ¿típicos o atípicos? Med Clin (Barc) 126 2006 415 417
28. A.L. Gruber-Baldini, B. Stuart, I.H. Zuckerman, L. Simoni-Wastila, and R. Miller Treatment of dementia in community-dwelling and institutionalized medicare beneficiaries J Am Geriatr Soc 55 2007 1508 1516
29. H. Brodaty, D. Ames, J. Snowdon, M. Woodward, J. Kirwan, R. Clarnette, et al. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia J Clin Psychiatry 64 2003 134 143
30. F. Formiga, I. Fort, J.M. Pérez-Castejón, D. Ruiz, E. Duaso, and S. Riu Association between risperidone treatment and cerebrovascular adverse events in elderly patients with dementia J Am Geriatr Soc 53 2005 1446 1448
31. F. Formiga, A. San José, A. López-Soto, A. Ruiz Durrutia, and E. Duaso Prevalencia de delírium en pacientes ingresados por procesos médicos Med Clin (Barc) 129 2007 571 573
32. C. Ballard, M.L. Hanney, M. Theodoulou, S. Douglas, R. McShane, K. Kossakowski, et al. for the DART-AD investigators The dementia antipsychotic with drawal trial (DART-AD): Long-term follow-up of a randomised placebo-controlled trial Lancet Neurol 8 2009 151 157